Skip to main content
Premium Trial:

Request an Annual Quote

Talking Cuts

Johnson and Johnson executives discussed the company's plan to cut 6 to 7 percent of its workforce and Jacob Goldstein at the Wall Street Journal's Health Blog blogged it live. The cuts, once all in place, are estimated to save the company $1.4 to $1.7 billion a year. Dominic Caruso, the J&J CFO, says that the "position eliminations" will be across all business and later adds that "the large majority of the [projected] savings are due to the workforce reductions." He also says that Johnson and Johnson will continue to cut "the overall level of R&D expense, particularly in the pharma business."

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.